{"nctId":"NCT01429077","briefTitle":"Augmenting Language Therapy for Aphasia: Levodopa","startDateStruct":{"date":"2007-10"},"conditions":["Nonfluent Aphasia","Stroke"],"count":36,"armGroups":[{"label":"Levodopa/carbidopa","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: levodopa/carbidopa"]},{"label":"Inactive pill","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo comparator"]}],"interventions":[{"name":"levodopa/carbidopa","otherNames":["Sinemet"]},{"name":"Placebo comparator","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* A single unilateral left-hemisphere stroke\n* Nonfluent aphasia, with a mean length of utterance of 0-4 words and an Aphasia Quotient between 20 and 75 on the Western Aphasia Battery\n* Age 21 or older.\n* At least 6 months post-stroke\n* Able to comply with the study protocol\n* Premorbidly right-handed, as determined by the Edinburgh Handedness Inventory\n* Fluent in English premorbidly\n* Completed at least 8th grade education\n\nExclusion Criteria:\n\n* More than one stroke\n* Any other neurological condition that could potentially affect cognition or speech.\n* Global aphasia or inability to participate in routine speech therapy.\n* Major active psychiatric illness that may interfere with required study procedures.\n* Untreated or inadequately treated depression.\n* Has started taking a potentially confounding central nervous system (CNS) drug within the previous 2 months.\n* Current abuse of alcohol or drugs\n* Nursing a child or pregnant\n* Participation in another drug, device or biologics trial within the preceding 90 days\n* Unable to understand, cooperate or comply with study procedures\n* Significant visual or auditory impairment\n* History of sensitivity to ergot derivatives.\n* Active medical illness or current medication that precludes safe participation in this study.","healthyVolunteers":false,"sex":"ALL","minimumAge":"21 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Language Quotient (LQ) on the Western Aphasia Battery","description":"Includes a measure of auditory comprehension, oral expression, reading and written expression skills.\n\nThe scale ranges from 1 - 100 with 100 being better. The change or gain score from baseline to immediately post-treatment (at 6 weeks) is reported. The larger the change score, the greater the improvement.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.16","spread":"3.63"},{"groupId":"OG001","value":"2.59","spread":"3.41"}]}]}]},{"type":"SECONDARY","title":"Functional Communication Skills","description":"Scores derived from language sample analyses","paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Participation in Everyday Activities","description":"Measures on CETI, QCL,BOSS, CCRSA.","paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Western Aphasia Battery - Reading and Writing Scores","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Western Aphasia Battery Aphasia Quotient (Maintenance)","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Western Aphasia Battery Reading and Writing Scores (Maintenance)","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Functional Communication Skills (Maintenance)","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Participation in Everyday Activities (Maintenance)","description":null,"paramType":null,"dispersionType":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":19},"commonTop":[]}}}